Cargando…

Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey

Purpose: COVID-19 reached Belgium in February and quickly became a major public health challenge. It is of importance to evaluate the actual impact of COVID-19 on patients and staff in Belgian radiotherapy departments (RTDs). This was evaluated through a weekly national survey sent to departments me...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaandering, Aude, Ben Mustapha, Selma, Lambrecht, Maarten, Van Gestel, Dirk, Veldmeman, Liv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017334/
https://www.ncbi.nlm.nih.gov/pubmed/33816310
http://dx.doi.org/10.3389/fonc.2021.654086
_version_ 1783674045248569344
author Vaandering, Aude
Ben Mustapha, Selma
Lambrecht, Maarten
Van Gestel, Dirk
Veldmeman, Liv
author_facet Vaandering, Aude
Ben Mustapha, Selma
Lambrecht, Maarten
Van Gestel, Dirk
Veldmeman, Liv
author_sort Vaandering, Aude
collection PubMed
description Purpose: COVID-19 reached Belgium in February and quickly became a major public health challenge. It is of importance to evaluate the actual impact of COVID-19 on patients and staff in Belgian radiotherapy departments (RTDs). This was evaluated through a weekly national survey sent to departments measuring key factors that were affected by the pandemic. Materials and Methods: The Belgian SocieTy for Radiation Oncology (BeSTRO) together with the Belgian College for physicians in Radiation Oncology invited all 26 RTD to participate in a survey that started on March 2nd and was re- submitted weekly for 4 months to assess variations in time. The survey focused on: (1) the COVID-19 status of patients and staff; (2) the management of clinically suspected COVID patients and COVID positive patients; (3) the impact of COVID-19 on RTD activities; (4) its impact in radiotherapy indications and fractionation schemes. Results: Seventy-three percent of 26 RTDs completed the first survey and 57% responded to all weekly surveys. In the RTD staff, 24 members were COVID-positive of whom 67% were RTTs. Over the study period, the number of patients treated dropped by a maximum of 18.8% when compared to March 2nd. In 32.3% of COVID-positive and 54% of COVID suspected patients, treatment was continued without any interruptions. Radiotherapy indications were adapted within the 1st weeks of the survey in 47.4% of RTD, especially for urological and breast tumors. Fractionation schemes were changed in 68.4% of RTD, mainly for urological, breast, gastro-intestinal, and lung tumors. Conclusions: Between March and June 2020, the COVID-19 pandemic resulted in an important decrease in treatment activity in RTD in Belgium (18.8%). The COVID-19 infection status of patients influenced the continuity of the radiotherapy schedule. Changes in indications and fractionation schedules of radiotherapy were rapidly incorporated in the different RTD.
format Online
Article
Text
id pubmed-8017334
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80173342021-04-03 Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey Vaandering, Aude Ben Mustapha, Selma Lambrecht, Maarten Van Gestel, Dirk Veldmeman, Liv Front Oncol Oncology Purpose: COVID-19 reached Belgium in February and quickly became a major public health challenge. It is of importance to evaluate the actual impact of COVID-19 on patients and staff in Belgian radiotherapy departments (RTDs). This was evaluated through a weekly national survey sent to departments measuring key factors that were affected by the pandemic. Materials and Methods: The Belgian SocieTy for Radiation Oncology (BeSTRO) together with the Belgian College for physicians in Radiation Oncology invited all 26 RTD to participate in a survey that started on March 2nd and was re- submitted weekly for 4 months to assess variations in time. The survey focused on: (1) the COVID-19 status of patients and staff; (2) the management of clinically suspected COVID patients and COVID positive patients; (3) the impact of COVID-19 on RTD activities; (4) its impact in radiotherapy indications and fractionation schemes. Results: Seventy-three percent of 26 RTDs completed the first survey and 57% responded to all weekly surveys. In the RTD staff, 24 members were COVID-positive of whom 67% were RTTs. Over the study period, the number of patients treated dropped by a maximum of 18.8% when compared to March 2nd. In 32.3% of COVID-positive and 54% of COVID suspected patients, treatment was continued without any interruptions. Radiotherapy indications were adapted within the 1st weeks of the survey in 47.4% of RTD, especially for urological and breast tumors. Fractionation schemes were changed in 68.4% of RTD, mainly for urological, breast, gastro-intestinal, and lung tumors. Conclusions: Between March and June 2020, the COVID-19 pandemic resulted in an important decrease in treatment activity in RTD in Belgium (18.8%). The COVID-19 infection status of patients influenced the continuity of the radiotherapy schedule. Changes in indications and fractionation schedules of radiotherapy were rapidly incorporated in the different RTD. Frontiers Media S.A. 2021-03-19 /pmc/articles/PMC8017334/ /pubmed/33816310 http://dx.doi.org/10.3389/fonc.2021.654086 Text en Copyright © 2021 Vaandering, Ben Mustapha, Lambrecht, Van Gestel and Veldmeman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Vaandering, Aude
Ben Mustapha, Selma
Lambrecht, Maarten
Van Gestel, Dirk
Veldmeman, Liv
Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey
title Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey
title_full Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey
title_fullStr Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey
title_full_unstemmed Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey
title_short Impact of the COVID-19 Pandemic on Patients and Staff in Radiation Oncology Departments in Belgium: A National Survey
title_sort impact of the covid-19 pandemic on patients and staff in radiation oncology departments in belgium: a national survey
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017334/
https://www.ncbi.nlm.nih.gov/pubmed/33816310
http://dx.doi.org/10.3389/fonc.2021.654086
work_keys_str_mv AT vaanderingaude impactofthecovid19pandemiconpatientsandstaffinradiationoncologydepartmentsinbelgiumanationalsurvey
AT benmustaphaselma impactofthecovid19pandemiconpatientsandstaffinradiationoncologydepartmentsinbelgiumanationalsurvey
AT lambrechtmaarten impactofthecovid19pandemiconpatientsandstaffinradiationoncologydepartmentsinbelgiumanationalsurvey
AT vangesteldirk impactofthecovid19pandemiconpatientsandstaffinradiationoncologydepartmentsinbelgiumanationalsurvey
AT veldmemanliv impactofthecovid19pandemiconpatientsandstaffinradiationoncologydepartmentsinbelgiumanationalsurvey